Skip to main content
. 2021 Feb 9;5:2470547020979780. doi: 10.1177/2470547020979780

Table 2.

Demographic and clinical characteristics of sample.

Prazosin (N = 32) Placebo (N = 35)
Age (years) 30.0 ± 6.6 30.8 ± 6.5
Education (years)* 13.3 ± 1.9 13.0 ± 2.1
Male 26 (81%) 31 (89%)
Race
 African American 4 (13%) 5 (14%)
 Asian 1 (3%) 0
 Caucasian 21 (66%) 21 (60%)
 Hispanic 5 (16%) 3 (9%)
 Native American 0 2 (6%)
 Other 1 (3%) 4 (11%)
Major depression 11 (34%) 15 (43%)
Maintenance Antidepressant 10 (31%) 13 (37%)

*Missing value for 3 Veterans in each group.